Reuters - Genetic tests could in future show who will respond best to Genentech and Roche’s blockbuster cancer drug Avastin — a positive development for patients but not necessarily for sales.
Independent honest reviews of most effective natural herbal supplements
Reuters - Genetic tests could in future show who will respond best to Genentech and Roche’s blockbuster cancer drug Avastin — a positive development for patients but not necessarily for sales.
The URI to TrackBack this entry is: http://herbal-review.com/2008/10/03/genetic-tests-may-pinpoint-who-should-get-avastin-reuters/trackback/
Please healthy :)
You must be logged in to post a comment.
|No results yet!
23 queries. 0.851 seconds